Fabienne Baur
Overview
Explore the profile of Fabienne Baur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lengsfeld S, Probst L, Emara Y, Werlen L, Vogt D, Bathelt C, et al.
EBioMedicine
. 2024 Sep;
107:105284.
PMID: 39232425
Background: The reward-regulatory properties of GLP-1 are attracting increasing interest. Animal studies show that GLP-1 receptor agonists not only reduce consumption of addictive substances, but also influence sexual behaviour. We...
2.
Luthi H, Lengsfeld S, Burkard T, Meienberg A, Jeanloz N, Vukajlovic T, et al.
EClinicalMedicine
. 2024 Feb;
68:102429.
PMID: 38371479
Background: Smoking cessation is challenging, despite making use of established smoking cessation therapies. Preclinical studies and one clinical pilot study suggest the antidiabetic drug glucagon-like peptide-1 (GLP-1) analogue to modulate...
3.
Baur F, Atila C, Lengsfeld S, Burkard T, Meienberg A, Bathelt C, et al.
BMJ Nutr Prev Health
. 2024 Jan;
6(2):301-309.
PMID: 38264360
Background: Women seem to have more difficulty quitting smoking than men. This is particularly concerning as smoking puts women at a higher risk of developing smoking-associated diseases. Greater concerns about...
4.
Monnerat S, Atila C, Baur F, Santos de Jesus J, Refardt J, Dickenmann M, et al.
Eur J Endocrinol
. 2023 Aug;
189(2):252-261.
PMID: 37540987
Importance: The syndrome of inappropriate antidiuresis (SIAD) can be treated with oral urea; however, compliance is impaired by its poor palatability. Objective: To investigate whether dietary proteins could increase plasma...
5.
Lengsfeld S, Burkard T, Meienberg A, Jeanloz N, Vukajlovic T, Bologna K, et al.
EClinicalMedicine
. 2023 Mar;
57:101865.
PMID: 36874396
Background: Quitting smoking is difficult due to barriers such as craving for cigarettes and post-cessation weight gain. Recent experimental data suggest a role of glucagon-like peptide-1 (GLP-1) in the pathophysiology...
6.
Vlajnic T, Baur F, Soysal S, Weber W, Piscuoglio S, Muenst S
Appl Immunohistochem Mol Morphol
. 2022 Sep;
30(10):726-730.
PMID: 36165931
Background: Assessment of programmed death protein-ligand 1 (PD-L1) in triple-negative breast cancer (TNBC) has entered daily practice to identify patients eligible for treatment with immune checkpoint inhibitors. However, different antibodies...